Traceability of pharmaceutical products as they move through the global supply chain. Regulations, technology standards, trading partner interoperability can all be barriers for companies seeking to gain the benefits of supply chain visibility and collaboration. Join SupplyScape in reviewing the key considerations and common misconceptions about pharmaceutical traceability.
Circulatory Shock, types and stages, compensatory mechanisms
Building A Global Pharmaceutical Traceability Foundation
1. Building a Global Traceability Foundation to Drive Visibility, Efficiency and Compliance Common Misconceptions and Key Considerations Robin Koh, Chief Strategy Officer, SupplyScape Corporation
2.
3. Safe & Secure Supply Chain Model Safe and Secure Supply Chain Pharmaceutical Co Wholesaler Pharmacy Chain of Custody Security Transaction Security Trace Track Pedigree Individual Product Security Product Security Product Authentication ID Authentication Authentication
4. Drivers For Global Traceability Regulatory Compliance Product Security Global Traceability Regulatory Compliance States considering pedigree laws / rules PDMA in effect. No state activity States with pedigree laws / rules today US Pedigree Regulations In place In development Global Serialization & Codification Regulations 70% Medical Professional 18% Subscriber Global Pharma Safety Incidents Sources: Organisation for Economic Co-operation and Development 964 04 196 02 484 03 1,123 05 1,412 06 1,759 07 Product Security Source: BCBSA Survey of Blue Plans’ Anti-Fraud Programs Reimburse In-accuracy 5% Med Unnec. 36% Services Not Rendered 9% Excess Charges 35% Other (1) 2% Pharm Fraud 4% Service Over Utilization 9% Upcoded Service
5.
6.
7.
8. Misconception #2: ‘Serialization has Limited ROI’ Least Realistic More Realistic CAPEX Packaging CAPEX ACF Program ACF Impact on Line Efficiency Additional Labor Data Monitoring CAPEX-Internal Additional Label Cost CAPEX CMO CAPEX DC Software Maintenance Recurring Benefit CAPEX - One Time Running Cost CAPEX IT Anti-Counterfeit Program #2 Patient Safety Program #1 Label Standardize Program Sales Enhancement Program #2 Anti-Counterfeit Program #1 Recall Enhancement Program Supply Chain Efficiency Program SC Visibility Program #1 Sales Enhancement Program #1 Data Reform Program Benefit Programs by Level of Effort Required and the Magnitude of Benefit Upside Potential Downside Impact
9.
10.
11.
12.
13.
14.
15.
16. Next Steps Get Started on Developing a Global Traceability Foundation Contact Mary Hall today to schedule a consultation! 781.503.7462, mhall@supplyscape.com Visit SupplyScape.com to learn more www.supplyscape.com